Search

Displaying results 7381 - 7390 of 7399 in total
  1. Drug

    CB-010

    go.drugbank.com/drugs/DB17711
    Investigational

    CB-010 is a CRISPR-edited allogeneic CAR-T cell therapy targeting CD19. It is being investigated for the treatment of follicular lymphoma.[L46158]

  2. Drug

    Cerdulatinib

    go.drugbank.com/drugs/DB15499
    Investigational

    Cerdulatinib is under investigation in clinical trial NCT04021082 (CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/refractory Peripheral T-cell Lymphoma (PTCL)).

  3. Drug

    CS1 CAR-T

    go.drugbank.com/drugs/DB33915
    Experimental

    CS1 CAR-T is a biologic drug. CS1 CAR-T is under investigation in clinical trial NCT07809594 (CS1-Targeted CAR-T Cells for Relapsed/Refractory Multiple Myeloma).

    Synonyms: CS1 CAR-T
  4. Drug

    Onametostat

    go.drugbank.com/drugs/DB21480
    Investigational

    The usage of the INN stem '-metostat' in the name indicates that Onametostat is a histone N-methyltransferase inhibitor.

  5. Drug

    Epsametostat

    go.drugbank.com/drugs/DB21726
    Experimental

    The usage of the INN stem '-metostat' in the name indicates that Epsametostat is a histone N-methyltransferase inhibitor. Epsametostat has a monoisotopic molecular weight of 611.28 Da.

  6. Drug

    177Lu-PSMA-I&T

    go.drugbank.com/drugs/DB22176
    Investigational

    177Lu-PSMA-I&T is under investigation in clinical trial NCT04886986 (Phase I/II 225Ac-J591 Plus 177Lu-PSMA-I&T for Progressive Metastatic Castration Resistant Prostate Cancer).

    Synonyms: 177Lu-PSMA I&T, 177Lu-PSMA-I&T
  7. Drug

    CTA30X UCAR-T

    go.drugbank.com/drugs/DB24819
    Investigational

    CTA30X UCAR-T is a biologic drug. CTA30X UCAR-T is under investigation in clinical trial NCT05015972 (UCAR-T for CD19+ Refractory/Relapsed B Hematologic Malignancies).

    Synonyms: CTA30X UCAR-T
  8. Drug

    Peldesine

    go.drugbank.com/drugs/DB02568
    Investigational

    Peldesine is a potent inhibitor of human CCRF-CEM T-cell proliferation. It has undergone phase I trials for the treatment of Human Immunodeficiency Virus (HIV) infections.

    Categories: N-Glycosyl Hydrolases, antagonists & inhibitors
  9. Drug

    5-Methoxy-N,N-diisopropyltryptamine

    go.drugbank.com/drugs/DB01441
    ExperimentalIllicit

    N,N-diethyltryptamine, bufotenine, psilocybin and psilocin. … 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) is a tryptamine derivative and shares many similarities with schedule I tryptamine hallucinogens such as alpha-ethyltryptamine, N,N-dimethyltryptamine,

    Synonyms: 5-Methoxy-N,N-diisopropyltryptamine, 5-methoxy-N,N-bis(1-methylethyl)-1H-indole-3-ethanamine
  10. Drug

    D-4-hydroxyphenylglycine

    go.drugbank.com/drugs/DB04308
    Experimental

    Synonyms: D-N-(4-Hydroxyphenyl)glycineCategories: Carnitine O-Palmitoyltransferase, antagonists & inhibitors